Thoratec Company Profile (NASDAQ:THOR)

About Thoratec

Thoratec logoThoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: THOR
  • CUSIP: 88517530
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $63.03
  • 200 Day Moving Average: $51.62
  • 52-Week Range: $25.04 - $63.51
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 39.44
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Thoratec:

Analyst Ratings

Consensus Ratings for Thoratec (NASDAQ:THOR) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $43.00 (32.28% downside)

Analysts' Ratings History for Thoratec (NASDAQ:THOR)
DateFirmActionRatingPrice TargetDetails
12/3/2015JPMorgan Chase & Co.Reiterated RatingNeutral$36.00 -> $43.00View Rating Details
11/2/2015Leerink SwannBoost Price TargetOutperform$32.00 -> $45.00View Rating Details
11/2/2015Canaccord GenuityBoost Price TargetBuy$39.00 -> $41.00View Rating Details
10/14/2015Goldman Sachs Group Inc.UpgradeHoldView Rating Details
9/29/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$56.00 -> $60.00View Rating Details
9/25/2015BTIG ResearchReiterated RatingNeutralView Rating Details
8/24/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/23/2015Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
7/22/2015Northland SecuritiesDowngradeOutperform -> Market Perform$55.00 -> $63.50View Rating Details
7/15/2015Oppenheimer Holdings Inc.Boost Price TargetOutperform$49.00 -> $52.00View Rating Details
5/8/2015Barclays PLCBoost Price TargetEqual Weight$40.00 -> $43.00View Rating Details
3/3/2015Credit Suisse Group AGSet Price TargetBuy$45.00View Rating Details
12/5/2014SunTrust Banks Inc.DowngradeBuy -> NeutralView Rating Details
11/6/2014Bank of America Corp.Reiterated RatingNeutral$29.00 -> $28.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Thoratec (NASDAQ:THOR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2015Q215$0.28$0.37$115.48 million$128.70 millionViewListenView Earnings Details
5/7/2015Q115$0.26$0.38$111.10 million$121.31 millionViewListenView Earnings Details
2/10/2015Q414$0.24$0.39$106.90 million$127.96 millionViewListenView Earnings Details
11/5/2014Q314$0.22$0.18$106.30 million$105.80 millionViewListenView Earnings Details
8/6/2014Q214$0.43$0.43$128.30 million$118.10 millionViewListenView Earnings Details
5/6/2014Q114$0.39$0.41$122.56 million$125.70 millionViewListenView Earnings Details
2/4/2014Q413$0.41$0.38$128.47 million$128.20 millionViewListenView Earnings Details
10/30/2013Q313$0.40$0.49$121.25 million$126.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.43$0.52$121.51 million$130.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.46$0.41$122.53 million$117.73 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.38$0.38$119.09 million$128.50 millionViewListenView Earnings Details
11/1/2012Q312$0.39$0.41$111.80 million$117.80 millionViewN/AView Earnings Details
8/1/2012$0.45$0.45ViewN/AView Earnings Details
5/1/2012$0.41$0.61ViewN/AView Earnings Details
11/1/2011$0.33$0.41ViewN/AView Earnings Details
8/3/2011$0.35$0.44ViewN/AView Earnings Details
5/3/2011$0.33$0.34ViewN/AView Earnings Details
1/27/2011$0.30$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thoratec (NASDAQ:THOR)
Current Year EPS Consensus Estimate: $1.37 EPS
Next Year EPS Consensus Estimate: $1.61 EPS


Dividend History for Thoratec (NASDAQ:THOR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Thoratec (NASDAQ:THOR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2015Neil F DimickDirectorSell8,173$44.98$367,621.54View SEC Filing  
5/15/2015Paul A LavioletteDirectorSell5,668$44.70$253,359.60View SEC Filing  
4/10/2015Neil F DimickDirectorSell4,786$43.00$205,798.00View SEC Filing  
12/4/2014J Daniel ColeDirectorSell5,000$31.83$159,150.00View SEC Filing  
5/27/2014Neil F DimickDirectorSell4,158$32.15$133,679.70View SEC Filing  
5/15/2014Paul LavioletteDirectorSell6,023$31.23$188,098.29View SEC Filing  
3/10/2014Gerhard BurbachCEOSell22,104$36.53$807,459.12View SEC Filing  
2/11/2014Gerhard BurbachCEOSell20,000$34.71$694,200.00View SEC Filing  
1/15/2014Gerhard BurbachCEOSell9,400$38.10$358,140.00View SEC Filing  
1/14/2014Gerhard BurbachCEOSell30,600$36.65$1,121,490.00View SEC Filing  
12/10/2013Gerhard BurbachCEOSell40,000$38.15$1,526,000.00View SEC Filing  
11/12/2013Gerhard BurbachCEOSell100,000$41.40$4,140,000.00View SEC Filing  
10/28/2013Gerhard F BurbachCEOSell15,000$40.02$600,300.00View SEC Filing  
10/17/2013Gerhard F BurbachCEOSell9,600$39.00$374,400.00View SEC Filing  
10/14/2013Gerhard BurbachCEOSell40,400$38.17$1,542,068.00View SEC Filing  
10/11/2013David Aaron LehmanSVPSell21,889$38.17$835,503.13View SEC Filing  
5/28/2013Neil F DimickDirectorSell1,273$31.58$40,201.34View SEC Filing  
5/20/2013Neil F DimickDirectorSell1,250$31.61$39,512.50View SEC Filing  
5/13/2013Neil F DimickDirectorSell1,250$33.93$42,412.50View SEC Filing  
11/26/2012Gerhard F BurbachCEOSell11,600$38.09$441,844.00View SEC Filing  
10/4/2012David Aaron LehmanSVPSell12,300$36.11$444,153.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Thoratec (NASDAQ:THOR)
News IconUnited States Intravenous Membrane Oxygenator Market Report 2016 (NASDAQ:THOR) - October 20 at 12:13 PM
News IconCardiac Assist Devices Market Size, Share and Forecast - 2019 (NASDAQ:THOR) - October 13 at 7:52 PM logoGlobal Cardiac Assist Devices Market Size, Share and Forecast - 2019 (NASDAQ:THOR) - October 13 at 11:36 AM
News IconGlobal Extracorporeal Liver Assist Device (ELAD) Sales Market Report 2016: Terumo Heart, Baxter International, Thoratec Corp., Abbott Diabetes Care (NASDAQ:THOR) - October 7 at 10:10 AM logoWinnebago Shares Surge 22% On Grand Design Acquisition, Baird Upgrade (NASDAQ:THOR) - October 3 at 7:07 PM
News IconGlobal LVAD Market Report: 2015 Edition | Now Available at (NASDAQ:THOR) - October 1 at 11:20 AM
News IconGlobal left ventricular assist systems (LVAS) market forecast to 2021 just published (NASDAQ:THOR) - September 28 at 7:26 PM
News Icon2016 Global Bio-Artificial Systems Industry 2021 Forecast Report (NASDAQ:THOR) - September 28 at 7:26 PM logoGlobal Artificial Organs Industry - Annual estimates and forecasts 2015 - 2022 (NASDAQ:THOR) - September 26 at 7:40 PM
News IconAustria Cardiac Assist Devices Market Outlook to 2022 - New Study Released (NASDAQ:THOR) - September 23 at 7:02 PM logoImpact of Existing and Emerging Cardiac Assist Devices Market Trends And Forecast 2015-2025 (NASDAQ:THOR) - September 23 at 7:02 PM
News IconCardiac Assist Devices Market Intelligence Report Offers Growth Prospects (NASDAQ:THOR) - September 15 at 7:47 PM
News IconCardiac Assist Devices Industry Global Research Report 2016 (NASDAQ:THOR) - September 15 at 7:47 PM logoGlobal Cardiac Assist Devices Market Analysis 2016 Forecasts to 2021 (NASDAQ:THOR) - September 13 at 9:53 AM logoReleases New Report on the Global Cardiac Assist Devices Market (NASDAQ:THOR) - September 6 at 7:47 PM
News IconCanada Cardiac Assist Devices Market Outlook to 2021 (NASDAQ:THOR) - September 2 at 7:32 PM
News IconGlobal LVAD Market Report: 2015 Edition provides a comprehensive analysis of the global market for LVAD, global BTT and DT market (NASDAQ:THOR) - August 26 at 10:40 AM logoVentricular Assist Device Market 2016 Review of MCS Industry With 2020 Forecasts (NASDAQ:THOR) - August 24 at 7:33 PM
News IconResearch report explores the global cardiac equipment market 2016: industry demand, segment, statistics and research to 2022 (NASDAQ:THOR) - August 23 at 12:16 PM
News IconGlobal Cardiac Equipment Market 2016: Industry Demand, Segment, Statistics and Research to 2022 (NASDAQ:THOR) - August 23 at 12:16 PM
News IconArtificial Organs Market : Segmentation, Industry trends and Developments 2021 (NASDAQ:THOR) - August 17 at 10:45 AM logoGlobal Cardiac Equipment Market 2016: Industry Review, Research, Statistics, and Growth to 2022 (NASDAQ:THOR) - August 16 at 7:53 PM
News IconCardiac Assist Devices Market Strategies and Forecasts, 2015-2025 (NASDAQ:THOR) - August 14 at 9:49 AM logoThoratec Corporation - Medical Equipment - Deals and Alliances Profile - New Market Research Report (NASDAQ:THOR) - August 14 at 9:49 AM
News IconWorldwide Cardiac Surgery Devices Market: Value Chain and Key Players (2016 - 2026) (NASDAQ:THOR) - August 12 at 7:57 PM logoGlobal Artificial Organ Bank Market to be Hampered by High Prices of Artificial Organs (NASDAQ:THOR) - August 10 at 8:20 PM
News IconLiraglutide does not improve clinical stability after hospitalization for HFrEF (NASDAQ:THOR) - August 4 at 8:15 PM logoResearch report covers the Cardiac Assist Devices Market share and Growth, 2015-2025 (NASDAQ:THOR) - August 4 at 11:00 AM
News IconMarket Forecast Report on Cardiac Assist Devices, 2015-2025 (NASDAQ:THOR) - July 30 at 10:32 AM
News IconCanada Cardiovascular Devices Market Research And Outlook To 2020 (NASDAQ:THOR) - July 26 at 8:16 PM
News IconMedtronic in $1.1bn deal to buy HeartWare (NASDAQ:THOR) - June 28 at 10:16 AM
News IconMedical device maker Medtronic to buy HeartWare for $1.1B (NASDAQ:THOR) - June 27 at 7:39 PM
News IconCardiac Equipment Industry Sales, Supply and Consumption 2016 Analysis and Forecasts to 2020 (NASDAQ:THOR) - June 21 at 7:16 PM logoCardiac Surgery Devices Market: Global Industry Analysis and Forecast 2016 - 2026 (NASDAQ:THOR) - June 19 at 9:49 AM logoGermany Cardiovascular Devices Market Outlook to 2021 - New Market Research Report (NASDAQ:THOR) - June 1 at 8:30 PM logoNew Study: Asia-Pacific Cardiac Assist Devices Market Outlook to 2021 (NASDAQ:THOR) - May 28 at 3:44 AM
News IconCalifornia Life Sciences Association Elects Leaders from Merck, Organovo and St. Jude Medical to its Board of Directors (NASDAQ:THOR) - May 25 at 11:39 AM logoNew Study: Italy Cardiac Assist Devices Market Outlook to 2021 (NASDAQ:THOR) - May 25 at 11:39 AM
News IconEU5's cardiac assist devices market share to 2021 made available by top research firm (NASDAQ:THOR) - May 17 at 12:30 PM logo2021 United States Cardiovascular Devices Market Analysis and Forecast (NASDAQ:THOR) - May 16 at 9:25 PM
News IconAsia-Pacific Cardiac Assist Devices Market Share,Supply and Consumption 2016 to 2021 Market Research Report (NASDAQ:THOR) - May 14 at 2:50 AM
News IconMechanical Circulatory Support in the New Era: An Overview (NASDAQ:THOR) - May 13 at 5:13 AM logoCardiac Assist Devices Market Dynamics, Forecast, Analysis and Supply Demand 2015-2025 (NASDAQ:THOR) - May 13 at 5:13 AM logoBrazil Cardiac Assist Devices Market Outlook to 2021 Fundamental Concepts and Current Research (NASDAQ:THOR) - May 12 at 6:16 AM logoChina Cardiac Assist Devices Market Outlook to 2021 Overview, Shares, Size and Forecast Report (NASDAQ:THOR) - May 10 at 10:19 PM
News IconCardiac Assist Devices Market in France Analysis for 2021 (NASDAQ:THOR) - May 10 at 10:19 PM
News IconSouth Korea Cardiac Assist Devices Market to 2021 – Analysis of Thoratec Corporation, Maquet Holding B.V. & Co. KG and Others (NASDAQ:THOR) - May 9 at 10:41 PM
News IconRecent research: 2021 Germany cardiac assist devices market research outlook (NASDAQ:THOR) - May 7 at 8:09 PM
News IconAbbott Laboratories acquires St. Jude Medical in $25B deal (NASDAQ:THOR) - May 6 at 6:10 AM
News IconAbbott Boosts Cardio Device Business With $25 Billion St. Jude Buy (NASDAQ:THOR) - May 5 at 2:37 AM


Thoratec (NASDAQ:THOR) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff